A retired senior executive with over 30 years of experience in the pharmaceutical and chemical industry. Has broad commercial experience in sales and marketing, including early and pre-launch product development, product launch, and life cycle management. Her experience includes Global and North American roles. President of AstraZeneca Canada from 2012-2015.
Global CFO of Teva – $45 billion market cap company from 1987-2008. Among his achievements – registered Teva on NASDAQ, multiple successful acquisitions and raised over $6 billion in the U.S. Started when sales were $28 million left when they reached $11 billion.
Mary L. Rotunno, J.D. is currently General Counsel and a Member of the Executive Leadership Team at El Camino Health, a $1.2 billion revenue health care system in Silicon Valley, California. Before joining El Camino Health in early 2014, Ms. Rotunno spent over 11 years as Senior Counsel and Client Service Leader for Common Spirit Health, formerly Dignity Health, in the San Francisco Bay Area. Prior to Dignity Health, she held various legal roles at Varian Medical Systems, Manatt, Phelps & Phillips, Golden Living, and Pillsbury Winthrop Shaw Pitman. Ms. Rotunno is on the Board of Directors of VistaGen Therapeutics (NASDAQ: VTGN) and she is also Chair of the Board for Momentum for Health, the largest provider of behavioural health services in Santa Clara County, California.
Ron has over fifteen years’ experience working in Growth Equity and Venture Capital investing, predominantly with Israeli related companies. Ron was a seven year partner with Shamrock (Disney) where he built the Israeli investing team and facilitated four IPO’s of Shamrock’s portfolio companies. Ron later served as a scout for Kleiner Perkins and was a senior international advisor to the Pritzker Group. Ron’s operational experience includes serving as CFO of Adgorithms, an Israel based AI marketing company, which Ron helped take public on the London Stock Exchange, raising over $40 million to the company and its shareholders.
Frances Kang is a venture capital investor at Horizons Ventures. Since joining in 2012, she has been leading many global technology investments, and working closely with entrepreneurs building disruptive companies globally. Many of her early investments have become multi-billion dollar businesses or public companies today, such as WeFox, N26, Blockstream, Airwallex, Ajaib, Hippo (NYSE: HIPO), Doma (NYSE: DOMA), Bakkt (NYSE: BKKT), etc. She has been on the Board of many highly dynamic, fast growing technology companies. Frances graduated from Stanford Graduate School of Business.